Insmed Incorporated
Clinical trials sponsored by Insmed Incorporated, explained in plain language.
-
Inhaler trial aims to help patients with rare, deadly lung combo breathe easier
Disease control Recruiting nowThis study is testing whether a new once-daily inhaled powder (TPIP) can help adults who have pulmonary hypertension caused by scarred lungs (interstitial lung disease). Over 300 participants will use either the real powder or a placebo for 24 weeks to see if it improves how far …
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Lifeline extended for patients in lung disease drug trial
Disease control AVAILABLEThis study provides continued access to an inhaled medication called TPIP for people with serious lung and heart conditions. It is for patients who have already successfully completed earlier long-term studies of this drug. The goal is to allow these patients to keep receiving a …
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC